Development of a visual attention based decision support system for autism spectrum disorder screening

Selda Ozdemir1, Isik Akin-Bulbul2, Ibrahim Kok3

  • 1Hacettepe University, Hacettepe Education Faculty, Department of Special Education, Beytepe, Ankara, Turkey.

Insights

This study developed a machine learning Decision Support System (DSS) to identify autism spectrum disorder (ASD) in young children. The system achieved an 87.5% success rate, highlighting visual attention as a key biomarker for early ASD assessment.

Area of Science:

  • Developmental psychology
  • Computational neuroscience
  • Biomedical engineering

Background:

  • Autism spectrum disorder (ASD) diagnosis in young children remains challenging.
  • Visual attention patterns have been previously identified as potential indicators in ASD.
  • Early identification of ASD is crucial for timely intervention and improved outcomes.

Purpose of the Study:

  • To develop and evaluate a Decision Support System (DSS) utilizing machine learning (ML) for early ASD identification.
  • To assess the efficacy of visual attention as a biomarker in distinguishing young children with ASD from typically developing (TD) peers.
  • To analyze the performance of the ML-based DSS in early ASD assessment.

Main Methods:

  • Development of a DSS employing machine learning algorithms.
  • Recruitment of young children aged 26–36 months, including those with ASD (n=61) and TD children (n=72).
  • Analysis of visual attention patterns as input features for the ML model.

Main Results:

  • The proposed DSS demonstrated a high success rate of up to 87.5% in the early assessment of ASD.
  • Machine learning techniques effectively differentiated between young children with ASD and TD children based on visual attention.
  • Visual attention was confirmed as a significant and promising biomarker for early ASD detection.

Conclusions:

  • The developed DSS shows significant potential for aiding in the early identification of ASD in young children.
  • Visual attention serves as a valuable and unique biomarker for early ASD assessment.
  • Further research is warranted to refine the DSS and explore its clinical applicability.

Related Concept Videos